Readressing the rationale of irradiation in stage I seminoma guidelines: a critical essay
2019-01-01 Berghen, C.; Albersen, M.; Blanchard, P.; Bossi, A.; Briganti, A.; Cozzarini, C.; Decaestecker, K.; Fonteyne, V.; Haustermans, K.; Joniau, S.; Lim Joon, D.; Khoo, V.; Nguyen, P. L.; Ost, P.; Villeirs, G.; Vulsteke, C.; Zietman, A.; De Meerleer, G.
Rates of lymph node invasion and their impact on cancer specific mortality in upper urinary tract urothelial carcinoma
2019-01-01 Nazzani, S.; Mazzone, E.; Preisser, F.; Tian, Z.; Mistretta, F. A.; Shariat, S. F.; Montanari, E.; Acquati, P.; Briganti, A.; Saad, F.; Carmignani, L.; Karakiewicz, P. I.
Postoperative paralytic ileus after major oncological procedures in the enhanced recovery after surgery era: A population based analysis
2019-01-01 Nazzani, S.; Bandini, M.; Preisser, F.; Mazzone, E.; Marchioni, M.; Tian, Z.; Stubinski, R.; Clementi, M. C.; Saad, F.; Shariat, S. F.; Montanari, E.; Briganti, A.; Carmignani, L.; Karakiewicz, P. I.
Oncologic outcomes after robot-assisted versus open radical cystectomy: a systematic review and meta-analysis
2019-01-01 Iwata, T.; Kimura, S.; Foerster, B.; Fossati, N.; Briganti, A.; Karakiewicz, P. I.; Gust, K. M.; Egawa, S.; Nasu, Y.; Abufaraj, M.; Shariat, S. F.
MRI-targeted biopsies: What’s next?
2019-01-01 Ploussard, G.; Briganti, A.
Impact of Tumor Size on Cancer-Specific Mortality Rate after Local Tumor Ablation in T1a Renal-Cell Carcinoma
2019-01-01 Palumbo, C.; Cyr, S. -J.; Mazzone, E.; Mistretta, F. A.; Knipper, S.; Pecoraro, A.; Tian, Z.; Shariat, S. F.; Saad, F.; Simeone, C.; Briganti, A.; Kapoor, A.; Antonelli, A.; Karakiewicz, P. I.
Impact of Obesity on Perioperative Outcomes at Robotic-assisted and Open Radical Prostatectomy: Results From the National Inpatient Sample
2019-01-01 Knipper, S.; Mazzone, E.; Mistretta, F. A.; Palumbo, C.; Tian, Z.; Briganti, A.; Saad, F.; Tilki, D.; Graefen, M.; Karakiewicz, P. I.
How cancer-specific mortality changes over time after radical cystectomy: Conditional survival of patients with nonmetastatic urothelial carcinoma of the urinary bladder
2019-01-01 Palumbo, C.; Mistretta, F. A.; Knipper, S.; Pecoraro, A.; Tian, Z.; Shariat, S. F.; Saad, F.; Simeone, C.; Briganti, A.; Antonelli, A.; Karakiewicz, P. I.
EAU-EANM-ESTRO-ESUR-SIOG Prostate Cancer Guideline Panel Consensus Statements for Deferred Treatment with Curative Intent for Localised Prostate Cancer from an International Collaborative Study (DETECTIVE Study)
2019-01-01 Lam, T. B. L.; Maclennan, S.; Willemse, P. -P. M.; Mason, M. D.; Plass, K.; Shepherd, R.; Baanders, R.; Bangma, C. H.; Bjartell, A.; Bossi, A.; Briers, E.; Briganti, A.; Buddingh, K. T.; Catto, J. W. F.; Colecchia, M.; Cox, B. W.; Cumberbatch, M. G.; Davies, J.; Davis, N. F.; De Santis, M.; Dell'Oglio, P.; Deschamps, A.; Donaldson, J. F.; Egawa, S.; Fankhauser, C. D.; Fanti, S.; Fossati, N.; Gandaglia, G.; Gillessen, S.; Grivas, N.; Gross, T.; Grummet, J. P.; Henry, A. M.; Ingels, A.; Irani, J.; Lardas, M.; Liew, M.; Lin, D. W.; Moris, L.; Omar, M. I.; Pang, K. H.; Paterson, C. C.; Renard-Penna, R.; Ribal, M. J.; Roobol, M. J.; Roupret, M.; Rouviere, O.; Sancho Pardo, G.; Richenberg, J.; Schoots, I. G.; Sedelaar, J. P. M.; Stricker, P.; Tilki, D.; Vahr Lauridsen, S.; van den Bergh, R. C. N.; Van den Broeck, T.; van der Kwast, T. H.; van der Poel, H. G.; van Leenders, G. J. L. H.; Varma, M.; Violette, P. D.; Wallis, C. J. D.; Wiegel, T.; Wilkinson, K.; Zattoni, F.; N'Dow, J. M. O.; Van Poppel, H.; Cornford, P.; Mottet, N.
The current and future role of the medical oncologist in the professional care for cancer patients: A position paper by the European Society for Medical Oncology (ESMO)
2014-01-01 Popescu, R. A.; Schäfer, R.; Califano, R.; Eckert, R.; Coleman, R.; Douillard, J. -Y.; Cervantes, A.; Casali, P. G.; Sessa, C.; van Cutsem, E.; de Vries, E.; Pavlidis, N.; Fumasoli, K.; Wörmann, B.; Samonigg, H.; Cascinu, S.; Hernández, J. J. Cruz; Howard, A. J.; Ciardiello, F.; Stahel, R. A.; Piccart, M.
VEGF and VEGFR genotyping in the prediction of clinical outcome for HCC patients receiving sorafenib: the ALICE-1 study
2014-01-01 Scartozzi, Mario; Faloppi, Luca; Svegliati Baroni, Gianluca; Loretelli, Cristian; Piscaglia, Fabio; Iavarone, Massimo; Toniutto, Pierluigi; Fava, Giammarco; De Minicis, Samuele; Mandolesi, Alessandra; Bianconi, Maristella; Giampieri, Riccardo; Granito, Alessandro; Facchetti, Floriana; Bitetto, Davide; Marinelli, Sara; Venerandi, Laura; Vavassori, Sara; Gemini, Stefano; D'Errico, Antonietta; Colombo, Massimo; Bolondi, Luigi; Bearzi, Italo; Benedetti, Antonio; Cascinu, Stefano
Androgen receptor expression in early triple-negative breast cancer: clinical significance and prognostic associations
2014-01-01 Pistelli, M; Caramanti, M; Biscotti, T; Santinelli, A; Pagliacci, A; De Lisa, M; Ballatore, Z; Ridolfi, F; Maccaroni, E; Bracci, R; Berardi, R; Battelli, N; Cascinu, Stefano
Thymic neoplasms: an update on the use of chemotherapy and new targeted therapies. A literature review
2014-01-01 Berardi, R; De Lisa, M; Pagliaretta, S; Onofri, A; Morgese, F; Savini, A; Ballatore, Z; Caramanti, M; Santoni, M; Mazzanti, P; Cascinu, Stefano
The role of LDH serum levels in predicting global outcome in HCC patients treated with sorafenib: implications for clinical management
2014-01-01 Faloppi, Luca; Scartozzi, Mario; Bianconi, Maristella; Svegliati Baroni, Gianluca; Toniutto, Pierluigi; Giampieri, Riccardo; Del Prete, Michela; De Minicis, Samuele; Bitetto, Davide; Loretelli, Cristian; D'Anzeo, Marco; Benedetti, Antonio; Cascinu, Stefano
Panitumumab versus cetuximab in patients with chemotherapy-refractory wild-type KRAS exon 2 metastatic colorectal cancer (ASPECCT): a randomised, multicentre, open-label, non-inferiority phase 3 study
2014-01-01 Price, Tj; Peeters, M; Kim, Tw; Li, J; Cascinu, Stefano; Ruff, P; Suresh, As; Thomas, A; Tjulandin, S; Zhang, K; Murugappan, S; Sidhu, R.
[11C]-Methionine Positron Emission Tomography in the Postoperative Imaging and Followup of Patients with Primary and Recurrent Gliomas
2014-01-01 Matteo, Santoni; Cristina, Nanni; Alessandro, Bittoni; Gabriele, Polonara; Alessandro, Paccapelo; Roberto, Trignani; Mariagrazia De, Lisa; Franco, Rychlicki; Luciano, Burattini; Rossana, Berardi; Stefano, Fanti; Cascinu, Stefano
Role of natural and adaptive immunity in renal cell carcinoma response to VEGFR-TKIs and mTOR inhibitor
2014-01-01 Santoni, M; Berardi, R; Amantini, C; Burattini, L; Santini, D; Santoni, G; Cascinu, Stefano
Locally advanced rectal cancer: the importance of a multidisciplinary approach
2014-01-01 Berardi, Rossana; Maccaroni, Elena; Onofri, Azzurra; Morgese, Francesca; Torniai, Mariangela; Tiberi, Michela; Ferrini, Consuelo; Cascinu, Stefano
Increased rates of local complication of central venous catheters in the targeted anticancer therapy era: a 2-year retrospective analysis
2015-01-01 Berardi, R.; Rinaldi, S.; Santini, D.; Vincenzi, B.; Giampieri, R.; Maccaroni, E.; Marcucci, F.; Francoletti, M.; Onofri, A.; Lucarelli, A.; Pierantoni, C.; Tonini, G.; Cascinu, Stefano
A phase I, dose-escalation study of volasertib combined with nintedanib in advanced solid tumors
2015-01-01 de Braud, Filippo; Cascinu, S.; Spitaleri, G.; Pilz, K.; Clementi, L.; Liu, D.; Sikken, P.; De Pas, T.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Readressing the rationale of irradiation in stage I seminoma guidelines: a critical essay | 1-gen-2019 | Berghen, C.; Albersen, M.; Blanchard, P.; Bossi, A.; Briganti, A.; Cozzarini, C.; Decaestecker, K.; Fonteyne, V.; Haustermans, K.; Joniau, S.; Lim Joon, D.; Khoo, V.; Nguyen, P. L.; Ost, P.; Villeirs, G.; Vulsteke, C.; Zietman, A.; De Meerleer, G. | |
| Rates of lymph node invasion and their impact on cancer specific mortality in upper urinary tract urothelial carcinoma | 1-gen-2019 | Nazzani, S.; Mazzone, E.; Preisser, F.; Tian, Z.; Mistretta, F. A.; Shariat, S. F.; Montanari, E.; Acquati, P.; Briganti, A.; Saad, F.; Carmignani, L.; Karakiewicz, P. I. | |
| Postoperative paralytic ileus after major oncological procedures in the enhanced recovery after surgery era: A population based analysis | 1-gen-2019 | Nazzani, S.; Bandini, M.; Preisser, F.; Mazzone, E.; Marchioni, M.; Tian, Z.; Stubinski, R.; Clementi, M. C.; Saad, F.; Shariat, S. F.; Montanari, E.; Briganti, A.; Carmignani, L.; Karakiewicz, P. I. | |
| Oncologic outcomes after robot-assisted versus open radical cystectomy: a systematic review and meta-analysis | 1-gen-2019 | Iwata, T.; Kimura, S.; Foerster, B.; Fossati, N.; Briganti, A.; Karakiewicz, P. I.; Gust, K. M.; Egawa, S.; Nasu, Y.; Abufaraj, M.; Shariat, S. F. | |
| MRI-targeted biopsies: What’s next? | 1-gen-2019 | Ploussard, G.; Briganti, A. | |
| Impact of Tumor Size on Cancer-Specific Mortality Rate after Local Tumor Ablation in T1a Renal-Cell Carcinoma | 1-gen-2019 | Palumbo, C.; Cyr, S. -J.; Mazzone, E.; Mistretta, F. A.; Knipper, S.; Pecoraro, A.; Tian, Z.; Shariat, S. F.; Saad, F.; Simeone, C.; Briganti, A.; Kapoor, A.; Antonelli, A.; Karakiewicz, P. I. | |
| Impact of Obesity on Perioperative Outcomes at Robotic-assisted and Open Radical Prostatectomy: Results From the National Inpatient Sample | 1-gen-2019 | Knipper, S.; Mazzone, E.; Mistretta, F. A.; Palumbo, C.; Tian, Z.; Briganti, A.; Saad, F.; Tilki, D.; Graefen, M.; Karakiewicz, P. I. | |
| How cancer-specific mortality changes over time after radical cystectomy: Conditional survival of patients with nonmetastatic urothelial carcinoma of the urinary bladder | 1-gen-2019 | Palumbo, C.; Mistretta, F. A.; Knipper, S.; Pecoraro, A.; Tian, Z.; Shariat, S. F.; Saad, F.; Simeone, C.; Briganti, A.; Antonelli, A.; Karakiewicz, P. I. | |
| EAU-EANM-ESTRO-ESUR-SIOG Prostate Cancer Guideline Panel Consensus Statements for Deferred Treatment with Curative Intent for Localised Prostate Cancer from an International Collaborative Study (DETECTIVE Study) | 1-gen-2019 | Lam, T. B. L.; Maclennan, S.; Willemse, P. -P. M.; Mason, M. D.; Plass, K.; Shepherd, R.; Baanders, R.; Bangma, C. H.; Bjartell, A.; Bossi, A.; Briers, E.; Briganti, A.; Buddingh, K. T.; Catto, J. W. F.; Colecchia, M.; Cox, B. W.; Cumberbatch, M. G.; Davies, J.; Davis, N. F.; De Santis, M.; Dell'Oglio, P.; Deschamps, A.; Donaldson, J. F.; Egawa, S.; Fankhauser, C. D.; Fanti, S.; Fossati, N.; Gandaglia, G.; Gillessen, S.; Grivas, N.; Gross, T.; Grummet, J. P.; Henry, A. M.; Ingels, A.; Irani, J.; Lardas, M.; Liew, M.; Lin, D. W.; Moris, L.; Omar, M. I.; Pang, K. H.; Paterson, C. C.; Renard-Penna, R.; Ribal, M. J.; Roobol, M. J.; Roupret, M.; Rouviere, O.; Sancho Pardo, G.; Richenberg, J.; Schoots, I. G.; Sedelaar, J. P. M.; Stricker, P.; Tilki, D.; Vahr Lauridsen, S.; van den Bergh, R. C. N.; Van den Broeck, T.; van der Kwast, T. H.; van der Poel, H. G.; van Leenders, G. J. L. H.; Varma, M.; Violette, P. D.; Wallis, C. J. D.; Wiegel, T.; Wilkinson, K.; Zattoni, F.; N'Dow, J. M. O.; Van Poppel, H.; Cornford, P.; Mottet, N. | |
| The current and future role of the medical oncologist in the professional care for cancer patients: A position paper by the European Society for Medical Oncology (ESMO) | 1-gen-2014 | Popescu, R. A.; Schäfer, R.; Califano, R.; Eckert, R.; Coleman, R.; Douillard, J. -Y.; Cervantes, A.; Casali, P. G.; Sessa, C.; van Cutsem, E.; de Vries, E.; Pavlidis, N.; Fumasoli, K.; Wörmann, B.; Samonigg, H.; Cascinu, S.; Hernández, J. J. Cruz; Howard, A. J.; Ciardiello, F.; Stahel, R. A.; Piccart, M. | |
| VEGF and VEGFR genotyping in the prediction of clinical outcome for HCC patients receiving sorafenib: the ALICE-1 study | 1-gen-2014 | Scartozzi, Mario; Faloppi, Luca; Svegliati Baroni, Gianluca; Loretelli, Cristian; Piscaglia, Fabio; Iavarone, Massimo; Toniutto, Pierluigi; Fava, Giammarco; De Minicis, Samuele; Mandolesi, Alessandra; Bianconi, Maristella; Giampieri, Riccardo; Granito, Alessandro; Facchetti, Floriana; Bitetto, Davide; Marinelli, Sara; Venerandi, Laura; Vavassori, Sara; Gemini, Stefano; D'Errico, Antonietta; Colombo, Massimo; Bolondi, Luigi; Bearzi, Italo; Benedetti, Antonio; Cascinu, Stefano | |
| Androgen receptor expression in early triple-negative breast cancer: clinical significance and prognostic associations | 1-gen-2014 | Pistelli, M; Caramanti, M; Biscotti, T; Santinelli, A; Pagliacci, A; De Lisa, M; Ballatore, Z; Ridolfi, F; Maccaroni, E; Bracci, R; Berardi, R; Battelli, N; Cascinu, Stefano | |
| Thymic neoplasms: an update on the use of chemotherapy and new targeted therapies. A literature review | 1-gen-2014 | Berardi, R; De Lisa, M; Pagliaretta, S; Onofri, A; Morgese, F; Savini, A; Ballatore, Z; Caramanti, M; Santoni, M; Mazzanti, P; Cascinu, Stefano | |
| The role of LDH serum levels in predicting global outcome in HCC patients treated with sorafenib: implications for clinical management | 1-gen-2014 | Faloppi, Luca; Scartozzi, Mario; Bianconi, Maristella; Svegliati Baroni, Gianluca; Toniutto, Pierluigi; Giampieri, Riccardo; Del Prete, Michela; De Minicis, Samuele; Bitetto, Davide; Loretelli, Cristian; D'Anzeo, Marco; Benedetti, Antonio; Cascinu, Stefano | |
| Panitumumab versus cetuximab in patients with chemotherapy-refractory wild-type KRAS exon 2 metastatic colorectal cancer (ASPECCT): a randomised, multicentre, open-label, non-inferiority phase 3 study | 1-gen-2014 | Price, Tj; Peeters, M; Kim, Tw; Li, J; Cascinu, Stefano; Ruff, P; Suresh, As; Thomas, A; Tjulandin, S; Zhang, K; Murugappan, S; Sidhu, R. | |
| [11C]-Methionine Positron Emission Tomography in the Postoperative Imaging and Followup of Patients with Primary and Recurrent Gliomas | 1-gen-2014 | Matteo, Santoni; Cristina, Nanni; Alessandro, Bittoni; Gabriele, Polonara; Alessandro, Paccapelo; Roberto, Trignani; Mariagrazia De, Lisa; Franco, Rychlicki; Luciano, Burattini; Rossana, Berardi; Stefano, Fanti; Cascinu, Stefano | |
| Role of natural and adaptive immunity in renal cell carcinoma response to VEGFR-TKIs and mTOR inhibitor | 1-gen-2014 | Santoni, M; Berardi, R; Amantini, C; Burattini, L; Santini, D; Santoni, G; Cascinu, Stefano | |
| Locally advanced rectal cancer: the importance of a multidisciplinary approach | 1-gen-2014 | Berardi, Rossana; Maccaroni, Elena; Onofri, Azzurra; Morgese, Francesca; Torniai, Mariangela; Tiberi, Michela; Ferrini, Consuelo; Cascinu, Stefano | |
| Increased rates of local complication of central venous catheters in the targeted anticancer therapy era: a 2-year retrospective analysis | 1-gen-2015 | Berardi, R.; Rinaldi, S.; Santini, D.; Vincenzi, B.; Giampieri, R.; Maccaroni, E.; Marcucci, F.; Francoletti, M.; Onofri, A.; Lucarelli, A.; Pierantoni, C.; Tonini, G.; Cascinu, Stefano | |
| A phase I, dose-escalation study of volasertib combined with nintedanib in advanced solid tumors | 1-gen-2015 | de Braud, Filippo; Cascinu, S.; Spitaleri, G.; Pilz, K.; Clementi, L.; Liu, D.; Sikken, P.; De Pas, T. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista39411
Data di pubblicazione
- In corso di stampa9
- 2020 - 202711498
- 2010 - 201915948
- 2000 - 20097460
- 1990 - 19993485
- 1980 - 1989933
- 1970 - 197977
- 1959 - 19591
Editore
- Elsevier Inc.802
- Elsevier B.V.771
- John Wiley and Sons Inc525
- Springer Science and Business Med...522
- Oxford University Press483
- Lippincott Williams and Wilkins420
- Springer362
- MDPI347
- Elsevier Ltd330
- Springer Nature282
Rivista
- EUROPEAN UROLOGY529
- BLOOD372
- PLOS ONE312
- JOURNAL OF NEUROLOGY283
- EUROPEAN JOURNAL OF HEART FAILURE280
- NEUROLOGY268
- DIGESTIVE AND LIVER DISEASE245
- EUROPEAN HEART JOURNAL224
- MULTIPLE SCLEROSIS216
- SCIENTIFIC REPORTS212
Keyword
- Humans3553
- Male2080
- Female1864
- Middle Aged1472
- Aged1290
- Adult1100
- COVID-19629
- Retrospective Studies628
- Treatment Outcome603
- Prognosis481
Lingua
- eng28818
- ita1958
- fre64
- und55
- spa34
- ger25
- por12
- enm6
- rus6
- grc3
Accesso al fulltext
- no fulltext33631
- open3381
- reserved2292
- partially open99
- embargoed7
- mixed1